Market Overview

According to fortune business insights, The global medical device contract manufacturing market size was valued at USD 87.43 billion in 2025. The market is projected to grow from USD 98.38 billion in 2026 to USD 252.95 billion by 2034, exhibiting a CAGR of 12.53% during the forecast period. North America dominated the medical device contract manufacturing market with a market share of 38% in 2025.

This analysis highlights the increasing reliance on specialized manufacturing partners with expertise in precision engineering, quality assurance, and regulatory compliance. The market supports a wide range of medical devices, from low-risk consumables to highly complex implantable systems. This trend indicates strong demand driven by innovation in medical technology, growing healthcare needs, and the need for scalable manufacturing solutions that ensure consistency, cost efficiency, and compliance with global quality standards.

Major Players Profiled in the Market Report:

• Jabil Inc. (Florida, U.S.)
• Thermo Fisher Scientific Inc. (Massachusetts, U.S.)
• Integer Holdings Corporation (Texas, U.S.)
• Flex Ltd. (Texas, U.S.)
• Sanmina Corporation (California, U.S.)
• Phillips-Medisize (Wisconsin, U.S.)
• Plexus Corp. (Wisconsin, U.S.)
• Viant (Massachusetts, U.S.)
• West Pharmaceutical Services, Inc. (Pennsylvania, U.S.)
• Mack (Vermont, U.S.)
• Cirtec (Minnesota, U.S.)
• Coghlin Companies, Inc. (Massachusetts, U.S.)

Segments

Strong Outsourcing for Moderately Complex Devices to Propel Class II Segment Growth

Based on product type, the market is divided into Class I, Class II, and Class III medical devices. The Class II segment holds the largest market share and dominates the market, representing nearly 44% of the share owing to strong outsourcing demand for diagnostic equipment, infusion systems, and monitoring devices that require greater regulatory oversight and performance validation.

High Demand for End-to-End Capabilities to Drive Device Manufacturing Segment Expansion